Artificial neural network for predicting pathological stage of clinically localized prostate cancer in a Taiwanese population

Journal of the Chinese Medical Association

Volumn 77, Issue 10, 2014, Pages 513-518

  Tsao, Chih Wei ^a,b   Liu, Ching Yu ^c   Cha, Tai Lung ^a   Wu, Sheng Tang ^a   Sun, Guang Huan ^a   Yu, Dah Shyong ^a   Chen, Hong I ^a,d   Chang, Sun Yran ^a,e   Chen, Shih Chang ^f   Hsu, Chien Yeh ^b  

^a TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^d CHANG JUNG CHRISTIAN UNIVERSITY   (Taiwan)

^e TAIPEI CITY HOSPITAL   (Taiwan)

^f NATIONAL TAIWAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

Author keywords

Artificial neural network; Capsule invasion; Partin tables; Prostate neoplasm

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; ARTIFICIAL NEURAL NETWORK; BODY MASS; CANCER LOCALIZATION; DIGITAL RECTAL EXAMINATION; GLEASON SCORE; HUMAN; HUMAN TISSUE; LAPAROSCOPIC SURGERY; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PREDICTION; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; TAIWANESE; TRANSRECTAL ULTRASONOGRAPHY; TUMOR INVASION; BLOOD; CANCER STAGING; PATHOLOGY; PROSTATE TUMOR; STATISTICAL MODEL;

AGED; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; NEOPLASM STAGING; NEURAL NETWORKS (COMPUTER); PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS;

EID: 84908099454     PISSN: 17264901     EISSN: 17287731     Source Type: Journal    
DOI: 10.1016/j.jcma.2014.06.014     Document Type: Article

References (27)

1. Oesterling J.E., Brendler C.B., Epstein J.I., Kimball A.W., Walsh P.C. Correlation of clinical stage, serum prostatic acid phosphatase and preoperative Gleason grade with final pathological stage in 275 patients with clinically localized adenocarcinoma of the prostate. J Urol 1987, 138:92-98.
2. Partin A.W., Yoo J., Carter H.B., Pearson J.D., Chan D.W., Epstein J.I., et al. The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer. J Urol 1993, 150:110-114.
3. Naito S., Kuroiwa K., Kinukawa N., Goto K., Koga H., Ogawa O., et al. Validation of Partin tables and development of a preoperative nomogram for Japanese patients with clinically localized prostate cancer using 2005 International Society of Urological Pathology consensus on Gleason grading: data from the Clinicopathological Research Group for Localized Prostate Cancer. J Urol 2008, 180:904-909.
4. Partin A.W., Kattan M.W., Subong E.N., Walsh P.C., Wojno K.J., Oesterling J.E., et al. Combination of prostate-specific antigen, clinical stage and Gleason score to predict pathological stage of localized prostate cancer. A multiinstutional update. JAMA 1997, 277:1445.
5. Partin A.W., Mangold L.A., Lamm D.M., Walsh P.C., Epstein J.I., Pearson J.D. Contemporary update of prostate cancer staging nomograms (Partin Tables) for the new millennium. Urology 2001, 58:843-848.
6. Makarov D.V., Trock B.J., Humphreys E.B., Mangold L.A., Walsh P.C., Epstein J.I., et al. Updated nomogram to predict pathologic stage of prostate cancer given prostate-specific antigen level, clinical stage, and biopsy Gleason score (Partin tables) based on cases from 2000 to 2005. Urology 2007, 69:1095-1101.
7. Fleming I.D., Cooper J.S., Henson D.E. AJCC cancer staging manual 1997, Lippincott-Raven, Philadelphia. 5th ed.
8. Krogh A. What are artificial neural networks?. Nat Biotechnol 2008, 26:195-197.
9. Rosenblatt F. The perceptron: a probabilistic model for information storage and organization in the brain. Psychological Review 1958, 65:386-408.
10. Snow P.B., Smith D.S., Catalona W.J. Artificial neural networks in the diagnosis and prognosis of prostate cancer: a pilot study. J Urol 1994, 152:1923-1926.
11. Tewari A., Narayan P. Novel staging tool for localized prostate cancer: a pilot study using genetic adaptive neural networks. J Urol 1998, 160:430-436.
12. Borque A., Sanz G., Allepuz C., Plaza L., Gil P., Rioja L.A. The use of neural networks and logistic regression analysis for predicting pathological stage in men undergoing radical prostatectomy: a population based study. J Urol 2001, 166:1672-1678.
13. Veltri R.W., Chaudhari M., Miller M.C., Poole E.C., O'Dowd G.J., Partin A.W. Comparison of logistic regression and neural net modeling for prediction of prostate cancer pathologic stage. Clin Chem 2002, 48:1828-1834.
14. Mattfeldt T., Kestler H.A., Hautmann R., Gottfried H.W. Prediction of postoperative prostatic cancer stage on the basis of systematic biopsies using two types of artificial neural networks. Eur Urol 2001, 39:530-536.
15. Matsui Y., Egawa S., Tsukayama C., Terai A., Kuwao S., Baba S., et al. Artificial neural network analysis for predicting pathological stage of clinically localized prostate cancer in the Japanese population. Jpn J Clin Oncol 2002, 32:530-535.
16. Ecke T.H., Bartel P., Hallmann S., Koch S., Ruttloff J., Cammann H., et al. Outcome prediction for prostate cancer detection rate with artificial neural network (ANN) in daily routine. Urol Oncol 2012, 30:139-144.
17. Mistry T., Digby J.E., Desai K.M., Randeva H.S. Obesity and prostate cancer: a role for adipokines. Eur Urol 2007, 52:46-53.
18. Meyerhardt J.A., Ma J., Courneya K.S. Energetics in colorectal and prostate cancer. J Clin Oncol 2010, 28:4066-4073.
19. Grossmann M., Wittert G. Androgens, diabetes and prostate cancer. Endocr Relat Cancer 2012, 19:F47-62.
20. Yoon D.K., Park J.Y., Yoon S., Park M.S., Moon du G., Lee J.G., et al. Can the prostate risk calculator based on Western population be applied to Asian population?. Prostate 2012, 72:721-729.
21. Bhojani N., Ahyai S., Graefen M., Capitanio U., Suardi N., Shariat S.F., et al. Partin Tables cannot accurately predict the pathological stage at radical prostatectomy. Eur J Surg Oncol 2009, 35:123-128.
22. Egawa S., Suyama K., Ohori M., Kawakami T., Kuwao S., Hirokado K., et al. Early detection of prostate cancer. Results of a prostate specific antigen-based detection program in Japan. Cancer 1995, 76:463-472.
23. Poulakis V., Witzsch U., De Vries R., Emmerlich V., Meves M., Altmannsberger H.M., et al. Preoperative neural network using combined magnetic resonance imaging variables, prostate specific antigen and Gleason score to predict prostate cancer stage. J Urol 2004, 172:1306-1310.
24. Stephan C., Jung K., Soosaipillai A., Yousef G.M., Cammann H., Meyer H., et al. Clinical utility of human glandular kallikrein 2 within a neural network for prostate cancer detection. BJU Int 2005, 96:521-527.
25. Stephan C., Meyer H.A., Cammann H., Nakamura T., Diamandis E.P., Jung K. Improved prostate cancer detection with a human kallikrein 11 and percentage free PSA-based artificial neural network. Biol Chem 2006, 387:801-805.
26. Salami S.S., Schmidt F., Laxman B., Regan M.M., Rickman D.S., Scherr D., et al. Combining urinary detection of TMPRSS2:ERG and PCA3 with serum PSA to predict diagnosis of prostate cancer. Urol Oncol 2013, 31:566-571.
27. Miyake H., Fujisawa M. Prognostic prediction following radical prostatectomy for prostate cancer using conventional as well as molecular biological approaches. Int J Urol 2013, 20:301-311.